Chainlink Faces Key $16.50 Barrier Amid ETF Approval Competition
- Chainlink’s LINK token trades in a $13–$26 range, stalled near $16.50 resistance amid profit-taking. - Bitwise’s Chainlink ETF (CLNK) appears on DTCC registry, signaling regulatory progress ahead of SEC approval. - Technical analysts highlight $17.65 as a key breakout threshold, with potential targets at $22.47–$47. - Institutional partnerships and $89B TVS underscore Chainlink’s market credibility amid ETF competition. - SEC’s auto-effective rules and Bitwise’s simplified structure may expedite approval
Chainlink’s native asset,
The DTCC registration, which
Technical analysis points to a potential decisive move for Chainlink’s price. Experts at Phemex noted that LINK has remained above the crucial $13 Fibonacci support, and a breakout past $17.65
The ETF’s regulatory journey has also attracted institutional attention. Interlink Electronics, a publicly listed company trading under the symbol LINK, reported an 11% year-over-year revenue increase for Q3, though its business is unrelated to the cryptocurrency. The shared ticker has occasionally led to confusion in discussions, but the spotlight remains on Chainlink’s blockchain-powered
Although the DTCC listing is encouraging, the approval process is still ongoing. Bitwise is required to
The broader market for altcoin ETFs is also gathering
As the market anticipates a clear breakout, the interaction between technical price points and regulatory updates will likely shape Chainlink’s next direction. With the SEC expected to resume full operations soon due to an upcoming funding bill, the near future could provide more certainty for both the ETF and LINK’s price movement. For now, investors should keep an eye on major support and resistance levels, as well as the SEC’s decision regarding Bitwise’s application.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
YFI has dropped 41.08% over the past year, experiencing fluctuating short-term movements.
- YFI fell 0.02% in 24 hours, 5.94% weekly, but rose 0.04% monthly amid 41.08% annual decline. - Price swings reflect mixed short-term stability and long-term fragility driven by macroeconomic factors. - Backtesting showed -2.15% average return post-41.08% annual drops, with no abnormal gains detected. - Market dynamics suggest prolonged consolidation rather than isolated events caused the sustained decline.
Solana News Today: Solana ETFs Signal Crypto's Move Into the Mainstream, Surpassing Bitcoin
- VanEck files Form 8-A for its Solana spot ETF (VSOL), signaling imminent Nasdaq launch after October S-1 registration. - 10 Solana ETFs await SEC approval as institutional demand grows for regulated access to the blockchain's ecosystem expansion in DeFi, NFTs, and staking. - Bitwise's first Solana ETF attracted $420M in its debut week, forcing competitors to accelerate strategies amid evolving regulatory pathways. - Strong institutional inflows ($421M in November) pushed SOL toward $168, though volatilit
ALGO experienced a 16.57% quarter-over-quarter decline due to product transitions and fluctuations in the market.
- ALGO fell 16.57% QoQ amid market volatility and product transition challenges at Alargo. - Alargo replaced Akaroid with NHD, achieving 80% YoY sales growth through direct doctor engagement. - AXI's margin optimization doubled contribution per piece despite 60% volume decline from low-margin delistings. - ARCO Pharma's rebranding and scientific training aims to strengthen pharmacist relationships and market position. - Analysts note long-term margin potential but warn of short-term revenue risks from tran
BCH Drops 1.35% Today as Loan Expansion Slows and Profitability Faces Challenges
- BCH fell 1.35% in 24 hours amid weak loan growth and reduced inflation adjustment income, with 60% revenue tied to net interest income. - Institutional holdings rose 12.75% but shares held dropped 3.53%, as Bridge Builder increased exposure while Baillie Gifford cut holdings by 289.93%. - Goldman Sachs maintains Neutral rating with 0.70% upside, while backtesting shows mixed post-earnings performance with limited statistical significance from two data points.